The same philosophy applies with e-readers . A state-of-the-art color reader from Amazon , Boox , or Kobo is pointless if you can't afford books for it. The good news is that as long as you don't care ...
Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.